Dignitana appoints DigniCap Dignitary with focus on ovarian cancer advocacy

Sharon Yapoujian kicks off Ovarian Cancer Awareness Month with insights on scalp cooling to reduce hair loss from chemotherapy

Dignitana, world leader in scalp cooling innovation, has appointed Sharon Yapoujian as a DigniCap Dignitarythe company’s patient advocacy and ambassador program. The announcement supports Dignitana’s recognition of Ovarian Cancer Awareness Month in September.

As a DigniCap Dignitary and ovarian cancer survivor, Yapoujian is eager to speak with cancer patients, especially women diagnosed with gynecological cancers like hers, about her personal scalp cooling experience. She will offer insights into hair care, comfort measures, emotional challenges, and differences between manual and automatic scalp cooling treatment options.

"Our DigniCap Dignitaries speak from a place of strength, persistence, and wisdom. They are using their voices to tell stories that only they can tell,” says William Cronin, Chief Executive Officer of Dignitana AB. “As more cancer centers offer scalp cooling to patients diagnosed with ovarian and other solid tumors, we know that Sharon’s experience will be deeply helpful to many. We are proud to include Sharon among our Dignitaries and appreciate her willingness to share personal experiences with others just beginning their cancer journeys.”

Launched in 2017, the DigniCap Dignitaries Program is an ever-expanding group of individuals who have used The DigniCap Scalp Cooling System and are passionate about playing a key role in increasing awareness about scalp cooling treatment for chemotherapy-induced hair loss. Through this program, Dignitaries connect with people and communities about how scalp cooling technology has positively improved quality of life during their cancer treatment.

“Identity, privacy and confidence became important and very personal concerns when I was diagnosed with cancer and put on a chemotherapy regimen,” said DigniCap Dignitary Sharon Yapoujian. “I’m incredibly honored by this opportunity to help others who I’m sure will have tons of questions, just as I did. To have someone who can help you know what to expect is so important. I can’t wait to connect with other cancer patients looking to keep their hair during chemo.”

Sharon Yapoujian hails from Aiken, South Carolina where she is an avid equestrian, a wife, and the mother of a three-year-old daughter. In April 2019 she was diagnosed with ovarian cancer and her medical team recommended she use DigniCap to maintain a sense of normalcy for herself, her husband, and, most importantly, her daughter. Through the DigniCap Dignitaries program Sharon will use her knowledge, positivity, and tenacity to serve as a beacon to others facing cancer and chemotherapy.

“As our partners at cancer centers nationwide can attest, DigniCap is more than just a device or part of a patient’s treatment,” adds Cronin. “Clinicians want to help patients maintain a level of privacy and control that is often lost after diagnosis. Helping cancer care teams address quality of life is an essential component of what we do every single day. Our DigniCap Dignitaries are just one more way we provide patients with a highly personalized level of support and care.”

Ovarian Cancer accounts for 3 percent of cancers in U.S. women, with 22,000 new diagnoses in the U.S. each year, and over 300,000 annual incidences worldwide. For Ovarian Cancer support contact the Ovarian Cancer Research Alliance or the National Ovarian Cancer Coalition

For More Information Contact

Caren Browning, King + Company,  caren.browning@kingcompr.com +1 212-561-7464

Investor Relations  investorrelations@dignitana.com  +1 469 518 5031

About Dignitana

Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and patient comfort. Hailed internationally as a life-changing medical advancement for cancer patients, The DigniCap Scalp Cooling System was invented in 1999 by a Swedish Oncology nurse and has been available in Europe since 2001.  Dignitana AB is listed on Nasdaq First North Growth Market in Sweden with headquarters in Lund, Sweden and operations based in Dallas, Texas in the United States.  Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy.  Erik Penser Bank AB, Certified Adviser, +46 (0) 8 463 83 00 certifiedadviser@penser.se www.penser.se  Learn more at www.dignitana.se and www.dignicap.com.